Search Results - "Valerius T"

Engineered CD3 antibodies for immunosuppression.

Authors: Renders, L. Valerius, T.

Source: Clinical & Experimental Immunology. Sep2003, Vol. 133 Issue 3, p307. 3p.

Organ-on-a-chip models for development of cancer immunotherapies.

Authors: Chernyavska, M. Masoudnia, M. Valerius, T. et al.

Source: Cancer Immunology, Immunotherapy. Dec2023, Vol. 72 Issue 12, p3971-3983. 13p.

Phase I clinical trial of the bispecific antibody MDX-H210 (anti-Fc?RI × anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer.

Authors: Repp, R. van Ojik, H.H. Valerius, T. et al.

Source: British Journal of Cancer. 12/15/2003, Vol. 89 Issue 12, p2234-2243. 10p.

The novel tribody [(CD20)2xCD16] efficiently triggers effector cell-mediated lysis of malignant B cells.

Authors: Glorius, P Baerenwaldt, A Kellner, C et al.

Source: Leukemia (08876924). Jan2013, Vol. 27 Issue 1, p190-201. 12p. 1 Chart, 7 Graphs.

Fusion proteins between ligands for NKG2D and CD20-directed single-chain variable fragments sensitize lymphoma cells for natural killer cell-mediated lysis and enhance antibody-dependent cellular cytotoxicity.

Authors: Kellner, C Hallack, D Glorius, P et al.

Source: Leukemia (08876924). Apr2012, Vol. 26 Issue 4, p830-834. 5p. 3 Graphs.

Bifunctional NHS-BAT Ester for Antibody Conjugation and Stable Technetium-99m Labeling: Conjugation Chemistry, Immunoreactivity and Kit Formulation.

Authors: Eisenhut, M. Lehmann, W. D. Becker, W. et al.

Source: Journal of Nuclear Medicine. Feb1996, Vol. 37 Issue 2, p362-370. 9p. 1 Black and White Photograph, 1 Diagram, 3 Charts, 6 Graphs.

Human kappa light chain targeted Pseudomonas exotoxin A — identifying human antibodies and Fab fragments with favorable characteristics for antibody–drug conjugate development

Authors: Kellner, C. Bleeker, W.K. Lammerts van Bueren, J.J. et al.

Source: Journal of Immunological Methods. Aug2011, Vol. 371 Issue 1/2, p122-133. 12p.

Serum-free production and purification of chimeric IgA antibodies

Authors: Beyer, T. Lohse, S. Berger, S. et al.

Source: Journal of Immunological Methods. Jul2009, Vol. 346 Issue 1/2, p26-37. 12p.

Low Dose Sirolimus in Combination with Mycophenolate Mofetil Improves Kidney Graft Function Late after Renal Transplantation and Suggests Pharmacokinetical Interaction of both Immunosuppressive Drugs.

Authors: Renders, L. Steinbach, R. Valerius, T. et al.

Source: Kidney & Blood Pressure Research. 2004, Vol. 27 Issue 5/6, p334-334. 1/3p.

HLA DR-directed bispecific single-chain Fv antibodies for lymphoma therapy.

Authors: Wachter, Y. Brünke, J. Schuster, S. et al.

Source: Cancer Cell International. 2004 Supplement 1, Vol. 4, pS4-1. 1p.

440 - Improvement of pharmacokinetics and myeloid effector cell engagement in vivo by Fc-engineering of IgA antibody against the epidermal growth factor receptor.

Authors: Rösner, T. Kretschmer, A. Lohse, S. et al.

Source: European Journal of Cancer. Dec2016 Supplement 1, Vol. 69, pS144-S144. 1p.

Optimization of complement recruitment in EGFR-directed antibody therapy.

Authors: Rösner, T. Derer, S. Klausz, K. et al.

Source: Molecular Immunology. Dec2013, Vol. 56 Issue 3, p267-267. 1p.

9229 POSTER Severe Central Nervous System (CNS) Graft Versus Host Disease (GVHD) in a Patient Without Any Other GvHD Symptoms After Allogeneic Stem Cell Transplantation

Authors: Schrader, C. Stingele, R. Brück, W. et al.

Source: European Journal of Cancer. Sep2011 Supplement 1, Vol. 47, pS647-S648. 0p.

Retargeted adenoviruses for local IgA and CD47 blocker production as a novel cancer therapy.

Authors: Chernyavska M Hartmann KP Jansen JHM et al.

Source: EMBO molecular medicine [EMBO Mol Med] 2026 Jul 07. Date of Electronic Publication: 2026 Jul 07.

Publication Type: Journal Article

Journal Info: Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE

Non-ICANS neurotoxicities CD19-directed CAR T-cell therapy and the emergence of movement and neurocognitive treatment-emergent adverse events: a case report.

Authors: Schroeder T Chitadze G Dargvainiene J et al.

Source: Frontiers in immunology [Front Immunol] 2026 Feb 16; Vol. 17, pp. 1749587. Date of Electronic Publication: 2026 Feb 16 (Print Publication: 2026).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Colonic spatial single-cell proteomics and murine models link mitochondrial dysfunction to dimeric IgA-secreting plasma cell deficiency in Crohn's disease.

Authors: Raschdorf A de Almeida LN Solbach P et al.

Corporate Authors: Raschdorf A de Almeida LN Solbach P et al.

Source: Nature communications [Nat Commun] 2026 Feb 12; Vol. 17 (1), pp. 1590. Date of Electronic Publication: 2026 Feb 12.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Blinatumomab-driven T-cell activation in αβ and γδ T-cell subsets: insights from in vitro assays.

Authors: Kelm M Nasr N Bendig S et al.

Source: Frontiers in immunology [Front Immunol] 2026 Feb 06; Vol. 17, pp. 1739493. Date of Electronic Publication: 2026 Feb 06 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Myeloid cell-mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interference.

Authors: Lustig M Kowol M Hartmann AM et al.

Source: Blood neoplasia [Blood Neoplasia] 2026 May 05; Vol. 3 (3), pp. 100242. Date of Electronic Publication: 2026 May 05 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918841988906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3280 (Electronic) Linking ISSN: 29503280 NLM ISO Abbreviation: Blood Neoplasia Subsets: PubMed not MEDLINE

Sialylation inhibition improves macrophage mediated tumor cell phagocytosis of breast cancer cells triggered by therapeutic antibodies of different isotypes.

Authors: Lustig M Hahn C Leangen Herigstad M et al.

Source: Frontiers in oncology [Front Oncol] 2024 Nov 26; Vol. 14, pp. 1488668. Date of Electronic Publication: 2024 Nov 26 (Print Publication: 2024).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Combination of Fc-Protein Engineering Strategies: Design and Evaluation of Antibody Effector Functions.

Authors: Gehlert CL Krohn S Winterberg D et al.

Source: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2026; Vol. 2998, pp. 399-420.

Publication Type: Journal Article

Journal Info: Publisher: Humana Press Country of Publication: United States NLM ID: 9214969 Publication Model: Print Cited Medium: Internet ISSN: 1940-6029 (Electronic) Linking ISSN: 10643745 NLM ISO Abbreviation: Methods Mol Biol Subsets: MEDLINE